A Role of Physical Activity in Patients with Systemic Sclerosis – a literature review
DOI:
https://doi.org/10.12775/JEHS.2024.70.51095Keywords
systemic sclerosis, connective tissue, activities, sportsAbstract
Introduction: Systemic sclerosis (SSc) is a chronic multisystem disease. The condition is characterized by extensive vascular dysfunction and progressive fibrosis of the skin and internal organs. The musculoskeletal, cardiac, pulmonary, and gastrointestinal systems are involved, resulting in a broad range of symptoms. Diagnosis is based on skin and/or internal organ fibrosis, production of specific autoantibodies, and evidence of vasculopathy
Purpose of work: Synthesis of knowledge about physical activity in patients with SSc.
Summary: Exercise and physiotherapy can improve the physical functions of patients with SSc. Physical activity in patients with SSc enhances hand function, enhances the function of the orofacial region, enhances sexual function, and also aids in coping with Raynaund's phenomenon, enhances physical capacity, alleviates fatigue as well and enhances general physical capacity. Furthermore, regular physical activity impeded the natural progression of progressive impairment of functional ability. Although, the literature regarding the efficacy and safety of exercise in patients with SSc is further insufficient.
References
Wu W, Jordan S, Graf N, de Oliveira Pena J, Curram J, Allanore Y, et al. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Ann Rheum Dis. 2019;78(5):648-56.
Khanna D, Denton CP. Evidence-based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol. 2010;24(3):387-400.
Bergamasco A, Hartmann N, Wallace L, Verpillat P. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol. 2019;11:257-73.
Bairkdar M, Rossides M, Westerlind H, Hesselstrand R, Arkema EV, Holmqvist M. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(7):3121-33.
Moinzadeh P, Kuhr K, Siegert E, Mueller-Ladner U, Riemekasten G, Günther C, et al. Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets. Rheumatology (Oxford). 2020;59(11):3380-9.
Suresh S, Charlton D, Snell EK, Laffoon M, Medsger TA, Jr., Zhu L, Domsic RT. Development of Pulmonary Hypertension in Over One-Third of Patients With Th/To Antibody-Positive Scleroderma in Long-Term Follow-Up. Arthritis Rheumatol. 2022;74(9):1580-7.
Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 2000;124(1):71-81.
Nikpour M, Hissaria P, Byron J, Sahhar J, Micallef M, Paspaliaris W, et al. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther. 2011;13(6):R211.
Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science. 2014;343(6167):152-7.
Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirják L, et al. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Annals of the rheumatic diseases. 2014;73(12):2087-93.
Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European heart journal. 2016;37(1):67-119.
Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, et al. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Arthritis care & research. 2014;66(10):1520-7.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737-47.
Melchor S, Joven BE, Andreu JL, Loza E, Garcia de Yebenes MJ, Carmona L, Carreira PE. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic. Semin Arthritis Rheum. 2016;46(3):350-5.
Foocharoen C, Ngamjarus C, Pattanittum P, Suwannaroj S, Pongkulkiat P, Onchan T, et al. Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health. Clin Rheumatol. 2023;42(7):1767-74.
Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58(12):3902-12.
LeRoy EC, Medsger TA, Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573-6.
Avouac J, Fransen J, Walker U, Riccieri V, Smith V, Muller C, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals of the Rheumatic Diseases. 2011;70(3):476-81.
Masi AT, Diagnostic SFSCotARA, Committee TC. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis & Rheumatism. 1980;23(5):581-90.
Steen VD. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg. 1998;17(1):48-54.
Song P, Li S, Lewis MA, Fiorentino DF, Chung L. Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis. JAMA Dermatol. 2023;159(3):308-13.
Valenzuela A, Song P, Chung L. Calcinosis in scleroderma. Curr Opin Rheumatol. 2018;30(6):554-61.
Volkmann ER, Andréasson K, Smith V. Systemic sclerosis. Lancet. 2023;401(10373):304-18.
Haque A, Hughes M. Raynaud's phenomenon. Clin Med (Lond). 2020;20(6):580-7.
Pope JE, Denton CP, Johnson SR, Fernandez-Codina A, Hudson M, Nevskaya T. State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol. 2023;19(4):212-26.
Fernández-Codina A, Walker KM, Pope JE. Treatment Algorithms for Systemic Sclerosis According to Experts. Arthritis Rheumatol. 2018;70(11):1820-8.
Cuomo G, Santoriello C, Polverino F, Ruocco L, Valentini G, Polverino M. Impaired exercise performance in systemic sclerosis and its clinical correlations. Scand J Rheumatol. 2010;39(4):330-5.
Pettersson H, Åkerström A, Nordin A, Svenungsson E, Alexanderson H, Boström C. Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls. Scand J Rheumatol. 2017;46(6):490-5.
Ross L, Costello B, Lindqvist A, Hansen D, Brown Z, Stevens W, et al. Disease specific determinants of cardiopulmonary fitness in systemic sclerosis. Semin Arthritis Rheum. 2023;58:152137.
Sezgin NH, Acar S, Savci S, Ozcan Kahraman B, Tanrıverdi A, Köken Avşar A, Birlik AM. Determinants of Six-Minute Walk Test Performance in Women with Systemic Sclerosis. J Musculoskelet Neuronal Interact. 2023;23(4):489-97.
Stöcker JK, Schouffoer AA, Spierings J, Schriemer MR, Potjewijd J, de Pundert L, et al. Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis. Rheumatology (Oxford). 2022;61(4):1476-86.
Willems LM, Vriezekolk JE, Schouffoer AA, Poole JL, Stamm TA, Boström C, et al. Effectiveness of Nonpharmacologic Interventions in Systemic Sclerosis: A Systematic Review. Arthritis Care Res (Hoboken). 2015;67(10):1426-39.
Horváth J, Bálint Z, Szép E, Deiszinger A, Minier T, Farkas N, et al. Efficacy of intensive hand physical therapy in patients with systemic sclerosis. Clin Exp Rheumatol. 2017;35 Suppl 106(4):159-66.
Seeger MW, Furst DE. Effects of splinting in the treatment of hand contractures in progressive systemic sclerosis. Am J Occup Ther. 1987;41(2):118-21.
Waszczykowski M, Dziankowska-Bartkowiak B, Podgórski M, Fabiś J, Waszczykowska A. Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients-one-year follow-up study. Sci Rep. 2021;11(1):15174.
Piga M, Tradori I, Pani D, Barabino G, Dessì A, Raffo L, Mathieu A. Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology. J Rheumatol. 2014;41(7):1324-33.
Landim SF, Bertolo MB, Marcatto de Abreu MF, Del Rio AP, Mazon CC, Marques-Neto JF, et al. The evaluation of a home-based program for hands in patients with systemic sclerosis. J Hand Ther. 2019;32(3):313-21.
Yuen HK, Marlow NM, Reed SG, Mahoney S, Summerlin LM, Leite R, et al. Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil. 2012;34(1):84-9.
Pizzo G, Scardina GA, Messina P. Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig. 2003;7(3):175-8.
Špiritović M, Šmucrová H, Heřmánková B, Oreská S, Štorkánová H, Rathouská A, et al. The effect of a 24-week physiotherapy and occupational therapy program in systemic sclerosis: a monocentric controlled study with follow-up. Clin Exp Rheumatol. 2022;40(10):1941-50.
Heřmánková B, Oreská S, Špiritović M, Štorkánová H, Komarc M, Pavelka K, et al. Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study. Aging Male. 2024;27(1):2336630.
Heřmánková B, Špiritović M, Šmucrová H, Oreská S, Štorkánová H, Komarc M, et al. Female Sexual Dysfunction and Pelvic Floor Muscle Function Associated with Systemic Sclerosis: A Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(1).
Heřmánková B, Špiritović M, Oreská S, Štorkánová H, Mann H, Pavelka K, et al. Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study. Rheumatol Ther. 2023;10(4):1089-105.
Tapia-Haro RM, García-Ríos MC, Castro-Sánchez AM, Toledano-Moreno S, Casas-Barragán A, Aguilar-Ferrándiz ME. Analysis of Hand Function, Upper Limb Disability, and Its Relationship with Peripheral Vascular Alterations in Raynaud's Phenomenon. Diagnostics (Basel). 2023;14(1).
Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, et al. ESVM guidelines - the diagnosis and management of Raynaud's phenomenon. Vasa. 2017;46(6):413-23.
Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford). 2016;55(10):1906-10.
Siegel P, Tencza M, Apodaca B, Poole JL. Effectiveness of Occupational Therapy Interventions for Adults With Rheumatoid Arthritis: A Systematic Review. Am J Occup Ther. 2017;71(1):7101180050p1-p11.
Cramp F, Hewlett S, Almeida C, Kirwan JR, Choy EH, Chalder T, et al. Non-pharmacological interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev. 2013(8):Cd008322.
Mitropoulos A, Boström C, Mattsson M, Kouidi E, Dimitroulas T, Liem SIE, et al. Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial. Trials. 2022;23(1):962.
Anifanti M, Teloudi A, Mitropoulos A, Syrakou N, Pagkopoulou E, Triantafyllidou E, et al. Right Ventricular Morphology and Function after Exercise Training in People with Systemic Sclerosis: A Randomized Controlled Pilot Study. Life (Basel). 2023;13(2).
Yakut H, Özalevli S, Birlik AM. Association between core stability and physical function, functional performance in patients with systemic sclerosis. Int J Rheum Dis. 2021;24(4):548-54.
Cetin SY, Calik BB, Ayan A. Investigation of the effectiveness of Tai Chi exercise program in patients with scleroderma: A randomized controlled study. Complement Ther Clin Pract. 2020;40:101181.
Filippetti M, Cazzoletti L, Zamboni F, Ferrari P, Caimmi C, Smania N, et al. Effect of a tailored home-based exercise program in patients with systemic sclerosis: A randomized controlled trial. Scand J Med Sci Sports. 2020;30(9):1675-84.
Sieczkowska SM, Smaira FI, Mazzolani BC, Gualano B, Roschel H, Peçanha T. Efficacy of home-based physical activity interventions in patients with autoimmune rheumatic diseases: A systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51(3):576-87.
Yakut H, Özalevli S, Aktan R, Özgen Alpaydın A, Merih Birlik A, Can G. Effects of supervised exercise program and home exercise program in patients with systemic sclerosis: A randomized controlled trial. Int J Rheum Dis. 2021;24(9):1200-12.
Antinozzi C, Grazioli E, De Santis M, Motta F, Sgrò P, Mari F, et al. The Preventive Role of Physical Activity in Systemic Sclerosis: A Cross-Sectional Study on the Correlation with Clinical Parameters and Disease Progression. Int J Environ Res Public Health. 2022;19(16).
Liem SIE, Vliet Vlieland TPM, Schoones JW, de Vries-Bouwstra JK. The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review. Rheumatol Adv Pract. 2019;3(2):rkz044.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Izabela Staniszewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 331
Number of citations: 0
